285 related articles for article (PubMed ID: 17548520)
1. Deubiquitinating enzyme CYLD negatively regulates the ubiquitin-dependent kinase Tak1 and prevents abnormal T cell responses.
Reiley WW; Jin W; Lee AJ; Wright A; Wu X; Tewalt EF; Leonard TO; Norbury CC; Fitzpatrick L; Zhang M; Sun SC
J Exp Med; 2007 Jun; 204(6):1475-85. PubMed ID: 17548520
[TBL] [Abstract][Full Text] [Related]
2. PKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytes.
Thuille N; Wachowicz K; Hermann-Kleiter N; Kaminski S; Fresser F; Lutz-Nicoladoni C; Leitges M; Thome M; Massoumi R; Baier G
PLoS One; 2013; 8(1):e53709. PubMed ID: 23335970
[TBL] [Abstract][Full Text] [Related]
3. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
Tsagaratou A; Grammenoudi S; Mosialos G
Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
[TBL] [Abstract][Full Text] [Related]
4. The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor β (TGF-β) signaling and the development of regulatory T cells.
Zhao Y; Thornton AM; Kinney MC; Ma CA; Spinner JJ; Fuss IJ; Shevach EM; Jain A
J Biol Chem; 2011 Nov; 286(47):40520-30. PubMed ID: 21931165
[TBL] [Abstract][Full Text] [Related]
5. Deubiquitinating enzyme CYLD regulates the peripheral development and naive phenotype maintenance of B cells.
Jin W; Reiley WR; Lee AJ; Wright A; Wu X; Zhang M; Sun SC
J Biol Chem; 2007 May; 282(21):15884-93. PubMed ID: 17392286
[TBL] [Abstract][Full Text] [Related]
6. The E3 ligase Itch and deubiquitinase Cyld act together to regulate Tak1 and inflammation.
Ahmed N; Zeng M; Sinha I; Polin L; Wei WZ; Rathinam C; Flavell R; Massoumi R; Venuprasad K
Nat Immunol; 2011 Nov; 12(12):1176-83. PubMed ID: 22057290
[TBL] [Abstract][Full Text] [Related]
7. The kinase TAK1 integrates antigen and cytokine receptor signaling for T cell development, survival and function.
Wan YY; Chi H; Xie M; Schneider MD; Flavell RA
Nat Immunol; 2006 Aug; 7(8):851-8. PubMed ID: 16799562
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the deubiquitinase CYLD in hepatocytes causes apoptosis, inflammation, fibrosis, and cancer.
Nikolaou K; Tsagaratou A; Eftychi C; Kollias G; Mosialos G; Talianidis I
Cancer Cell; 2012 Jun; 21(6):738-50. PubMed ID: 22698400
[TBL] [Abstract][Full Text] [Related]
9. TAK1-JNK axis mediates survival signal through Mcl1 stabilization in activated T cells.
Hirata Y; Sugie A; Matsuda A; Matsuda S; Koyasu S
J Immunol; 2013 May; 190(9):4621-6. PubMed ID: 23547112
[TBL] [Abstract][Full Text] [Related]
10. LRRC62 attenuates Toll-like receptor signaling by deubiquitinating TAK1 via CYLD.
Zhang J; Ou J; Wan X
Exp Cell Res; 2019 Oct; 383(1):111497. PubMed ID: 31301291
[TBL] [Abstract][Full Text] [Related]
11. Dual-specificity phosphatase 14 (DUSP14/MKP6) negatively regulates TCR signaling by inhibiting TAB1 activation.
Yang CY; Li JP; Chiu LL; Lan JL; Chen DY; Chuang HC; Huang CY; Tan TH
J Immunol; 2014 Feb; 192(4):1547-57. PubMed ID: 24403530
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor cylindromatosis acts as a negative regulator for Streptococcus pneumoniae-induced NFAT signaling.
Koga T; Lim JH; Jono H; Ha UH; Xu H; Ishinaga H; Morino S; Xu X; Yan C; Kai H; Li JD
J Biol Chem; 2008 May; 283(18):12546-54. PubMed ID: 18332137
[TBL] [Abstract][Full Text] [Related]
13. TGF-β1-activated kinase-1 regulates inflammation and fibrosis in the obstructed kidney.
Ma FY; Tesch GH; Ozols E; Xie M; Schneider MD; Nikolic-Paterson DJ
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1410-21. PubMed ID: 21367917
[TBL] [Abstract][Full Text] [Related]
14. Alternative Splice Forms of CYLD Mediate Ubiquitination of SMAD7 to Prevent TGFB Signaling and Promote Colitis.
Tang Y; Reissig S; Glasmacher E; Regen T; Wanke F; Nikolaev A; Gerlach K; Popp V; Karram K; Fantini MC; Schattenberg JM; Galle PR; Neurath MF; Weigmann B; Kurschus FC; Hövelmeyer N; Waisman A
Gastroenterology; 2019 Feb; 156(3):692-707.e7. PubMed ID: 30315770
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinating enzyme cylindromatosis mitigates nonalcoholic steatohepatitis.
Ji YX; Huang Z; Yang X; Wang X; Zhao LP; Wang PX; Zhang XJ; Alves-Bezerra M; Cai L; Zhang P; Lu YX; Bai L; Gao MM; Zhao H; Tian S; Wang Y; Huang ZX; Zhu XY; Zhang Y; Gong J; She ZG; Li F; Cohen DE; Li H
Nat Med; 2018 Feb; 24(2):213-223. PubMed ID: 29291351
[TBL] [Abstract][Full Text] [Related]
16. CYLD Deubiquitinates Nicotinamide Adenine Dinucleotide Phosphate Oxidase 4 Contributing to Adventitial Remodeling.
Yu B; Liu Z; Fu Y; Wang Y; Zhang L; Cai Z; Yu F; Wang X; Zhou J; Kong W
Arterioscler Thromb Vasc Biol; 2017 Sep; 37(9):1698-1709. PubMed ID: 28751569
[TBL] [Abstract][Full Text] [Related]
17. Thymocyte-specific truncation of the deubiquitinating domain of CYLD impairs positive selection in a NF-kappaB essential modulator-dependent manner.
Tsagaratou A; Trompouki E; Grammenoudi S; Kontoyiannis DL; Mosialos G
J Immunol; 2010 Aug; 185(4):2032-43. PubMed ID: 20644164
[TBL] [Abstract][Full Text] [Related]
18. Regulation of early wave of germ cell apoptosis and spermatogenesis by deubiquitinating enzyme CYLD.
Wright A; Reiley WW; Chang M; Jin W; Lee AJ; Zhang M; Sun SC
Dev Cell; 2007 Nov; 13(5):705-716. PubMed ID: 17981138
[TBL] [Abstract][Full Text] [Related]
19. USP18 inhibits NF-κB and NFAT activation during Th17 differentiation by deubiquitinating the TAK1-TAB1 complex.
Liu X; Li H; Zhong B; Blonska M; Gorjestani S; Yan M; Tian Q; Zhang DE; Lin X; Dong C
J Exp Med; 2013 Jul; 210(8):1575-90. PubMed ID: 23825189
[TBL] [Abstract][Full Text] [Related]
20. Polyubiquitination of Transforming Growth Factor β-activated Kinase 1 (TAK1) at Lysine 562 Residue Regulates TLR4-mediated JNK and p38 MAPK Activation.
Chen IT; Hsu PH; Hsu WC; Chen NJ; Tseng PH
Sci Rep; 2015 Jul; 5():12300. PubMed ID: 26189595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
